首页> 外文期刊>Translational Oncology >Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection
【24h】

Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection

机译:术前中性粒细胞与淋巴细胞比值作为肝癌根治性切除术后新的预后指标

获取原文
           

摘要

BACKGROUND : Preoperative peripheral blood neutrophil-to-lymphocyte ratio (NLR) has been proposed to predict prognosis of hepatocellular carcinoma (HCC). However, the cutoff value of NLR in several studies is not consistent. This study aims to investigate the correlation of preoperative NLR with clinicopathologic features and the prognosis in patients who have undergone resection for HCC. METHODS : Clinical data of 256 patients with HCC who underwent radical hepatectomy were retrospectively analyzed. The patients were divided into the low-NLR group (NLR ≤ 2.31) and the high-NLR group (NLR > 2.31). A univariate analysis was performed to assess clinicopathologic characteristics that influenced disease-free survival (DFS) and overall survival (OS) in patients. The significant variables were further analyzed by a multivariate analysis using Cox regression. The Kaplan-Meier method was used to assess the DFS and OS rate. RESULTS : The value of NLR was associated with tumor size, clinical tumor-node-metastasis (TNM) stage, portal vein tumor thrombus (PVTT), distant metastasis, and aspartate aminotransferase (AST) in HCC. NLR > 2.31, size of tumor > 5 cm, number of multiple tumors, III-IV of TNM stage, PVTT, distant metastasis, and AST > 40 U/l were predictors of poorer DFS and OS. NLR > 2.31, size of tumor >5 cm, III-IV of TNM stage, and AST > 40 U/l were independent predictors of DFS and OS. CONCLUSION : Preoperative NLR > 2.31 was an adverse predictor of DFS and OS in HCC after hepatectomy. This study suggested that NLR might be a novel prognostic biomarker in HCC after curative resection.
机译:背景:术前外周血中性粒细胞与淋巴细胞之比(NLR)已被提议用于预测肝细胞癌(HCC)的预后。但是,在一些研究中,NLR的临界值不一致。本研究旨在探讨术前NLR与肝癌切除患者的临床病理特征和预后的关系。方法:对256例行根治性肝切除术的HCC患者的临床资料进行回顾性分析。将患者分为低NLR组(NLR≤2.31)和高NLR组(NLR> 2.31)。进行单因素分析以评估影响患者无病生存期(DFS)和总体生存期(OS)的临床病理特征。使用Cox回归通过多变量分析进一步分析显着变量。 Kaplan-Meier方法用于评估DFS和OS速率。结果:NLR的值与HCC中的肿瘤大小,临床肿瘤淋巴结转移(TNM)分期,门静脉肿瘤血栓(PVTT),远处转移和天冬氨酸转氨酶(AST)相关。 NLR> 2.31,肿瘤大小> 5 cm,多发肿瘤数目,TNM分期的III-IV,PVTT,远处转移和AST> 40 U / l是DFS和OS较差的预测指标。 NLR> 2.31,肿瘤大小> 5 cm,TNM分期的III-IV和AST> 40 U / l是DFS和OS的独立预测因子。结论:术前NLR> 2.31是肝切除术后HCC中DFS和OS的不良预测指标。这项研究表明,NLR可能是根治性切除后肝癌的一种新的预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号